Menopause depression: Under recognised and poorly treated

Jayashri Kulkarni, Caroline Gurvich, Eveline Mu, Grace Molloy, Sonya Lovell, Ginni Mansberg, Shelly Horton, Erin Morton, Talat Uppal, Ceri Cashell, Anthony de Castella, Dan Reisel, Linda Dear, Naomi Weatherburn-Reeves, Katie Harris, Kerry Pietrobon, Kelly Teagle, Bo Youn Kim, Louise Newson, Cassandra Szoeke

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)

Abstract

Menopause is a biological process experienced by all people assigned female at birth. A significant number of women experience mental ill health related to the major brain gonadal hormone shifts that occur in their midlife. There is poor understanding and management of the complex mental ill health issues, with the biological brain hormone changes receiving little formal attention. The current treatment advice is to manage this special type of mental ill health in the same way that all mental ill health is managed. This leads to poor outcomes for women and their families. Many women leave the workforce earlier than expected due to menopause-related depression and anxiety, with subsequent loss of salary and superannuation. Others describe being unable to adequately parent or maintain meaningful relationships – all ending in a poor quality of life. We are a large and diverse group of national and international clinicians, lived experience and social community advocates, all working together to innovate the current approaches available for women with menopausal mental ill health. Above all, true innovation is only possible when the woman with lived experience of menopause is front and centre of this debate.

Original languageEnglish
Pages (from-to)636-640
Number of pages5
JournalAustralian and New Zealand Journal of Psychiatry
Volume58
Issue number8
DOIs
Publication statusPublished - Aug 2024

Keywords

  • gonadal hormones
  • Menopause
  • menopause hormone therapy

Cite this